View this email as a web page here.

Biomarker Discovery with SMCTM Technology

Biomarker Discovery with SMCTM Technology

Biomarkers are measurable characteristics that serve as reflections of biological states or signs of specific conditions. The vast majority of biomarkers found in disease research are proteins, which are highly reflective of—and relevant to—pathophysiological status. Researchers have recently become interested in early disease detection because identifying signs of nascent pathogenesis offers tremendous advantages for combating many illnesses. Biomarkers involved in early disease detection often exist at lower concentrations than in symptomatic disease mechanisms. As such, greater assay sensitivity is required to locate and quantify them.

Download this ebook from MilliporeSigma to learn about the importance of biomarkers and how ultrasensitive Single Molecule Counting (SMC™) technology drives disease-based biomarker research forward.



Never miss an email from The Scientist.
Click here to add The Scientist to your safe-sender list.

The Scientist, 1000 N West Street, Suite 1200, 
Wilmington, Delaware, United States, 19801  
Toll-Free: (888) 781-0328 | Phone: (705) 528-6888

You received this email because you are subscribed to The Scientist Special Offers and Promotions from The Scientist.
Click to Unsubscribe | View Privacy Policy

Stop receiving email from The Scientist